Secondary Immune Thrombocytopenic Purpura in Renal Cell Cancer: A Paraneoplastic Syndrome.

immune thrombocytopenic purpura paraneoplastic syndrome renal cell cancer

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
05 Apr 2019
Historique:
entrez: 28 6 2019
pubmed: 28 6 2019
medline: 28 6 2019
Statut: epublish

Résumé

Secondary immune thrombocytopenic purpura (ITP) as a paraneoplastic syndrome has been reported in literature. It is commonly associated with chronic lymphocytic leukemia (CLL) and hodgkins lymphoma. Its association with solid malignancies, especially renal cell cancer is rare, with only a few documented case reports. Treatment usually consisted of targeting the underlying malignancy or utilization of steroid and intravenous immunoglobulin (IVIG) to improve thrombocytopenia. Here, we describe a case of a 75-year-old man with renal cell cancer (RCC), who presented with secondary thrombocytopenia treated with steroid and IVIG. It is important to keep RCC in differential diagnosis for causes for secondary ITP as this impacts treatment.

Identifiants

pubmed: 31245188
doi: 10.7759/cureus.4398
pmc: PMC6559687
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e4398

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Thromb Haemost. 1999 Sep;82(3):1005-7
pubmed: 10494753
J Urol. 2002 Mar;167(3):1395
pubmed: 11832746
Am J Clin Oncol. 2004 Aug;27(4):333-6
pubmed: 15289724
Semin Arthritis Rheum. 2006 Apr;35(5):322-32
pubmed: 16616155
Thromb Diath Haemorrh. 1975 Sep 30;34(1):181-93
pubmed: 171794
Semin Hematol. 2009 Jan;46(1 Suppl 2):S2-14
pubmed: 19245930
Wien Klin Wochenschr. 2010 Apr;122(7-8):229-36
pubmed: 20503022
Crit Rev Oncol Hematol. 2012 Jan;81(1):75-81
pubmed: 21515071
Korean J Intern Med. 2014 Sep;29(5):671-4
pubmed: 25228845
Intern Med J. 2015 Jun;45(6):666-9
pubmed: 26059878
Br J Urol. 1989 Feb;63(2):212-3
pubmed: 2702413
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):568-575
pubmed: 30504359
J Community Hosp Intern Med Perspect. 2019 Feb 11;9(1):59-61
pubmed: 30788080
Medicine (Baltimore). 1979 Sep;58(5):377-84
pubmed: 481196
Leuk Lymphoma. 1994 Sep;15(1-2):187-8
pubmed: 7858499
J Pathol. 1997 Oct;183(2):131-3
pubmed: 9390023

Auteurs

Arish Noor (A)

Internal Medicine, University of Connecitcut, Hartford, USA.

Anam Rehan (A)

Internal Medicine, University of Connecticut, Hartford, USA.

Aakash Desai (A)

Internal Medicine, University of Connecticut, Hartford, USA.

Corina Iorgoveanu (C)

Internal Medicine, University of Connecticut, Hartford, USA.

Jim C Lee (JC)

Pathology, Hartford Hospital, Hartford, USA.

Classifications MeSH